Dr. Charles B. Simone, II, Chief Medical Office of the New York Proton Center, has been named a Fellow of the American College of Radiation Oncology (FACRO). Fellowships are awarded to those who meet rigorous criteria of outstanding service to the College and the specialty of radiation oncology. Most importantly, recipients are honored for carrying out efforts that benefit the patients they serve. Being recognized as a Fellow of the American College of Radiation Oncology is one of the most prestigious honors the College can bestow on a member.
Dr. Simone is an internationally recognized expert in the use of proton therapy to treat thoracic malignancies and for reirradiation. He has developed clinical trial strategies and innovative research in thoracic radiation oncology and stereotactic body radiation therapy. “At the New York Proton Center, we have carefully assembled a team of clinical experts with longstanding experience in proton therapy and who have a commitment to the well-being of their patients,” said Allan Freeman, Chief Executive Officer at the New York Proton Center. “Dr. Simone’s depth of expertise in radiation oncology is pivotal as we establish the region’s foremost destination for proton therapy right here in Manhattan.”
Dr. Simone is also a National Institutes of Health, National Science Foundation, and Department of Defense funded investigator who performs clinical and translational research investigating the benefits of proton therapy as part of multi-modality therapy for thoracic malignancies. Dr. Simone was granted an Accelerated FACRO appointment – with his Fellowship awarded much earlier than the College usually gives this distinguished recognition – due to his multiple leadership positions within the College and significant contributions to the general field of oncology, as exemplified by more than 300 published peer-reviewed scientific articles and book chapters and nearly 200 scientific lectures for national and international audiences.
The American College of Radiation Oncology is managed by an elected board of volunteers with the purpose of ensuring the highest quality care for radiation oncology patients and promoting success in the practice of radiation oncology through education, responsible socioeconomic advocacy, and integration of science and technology into clinical practice.
The New York Proton Center is creating the gold standard for proton therapy, giving patients new hope in their fight against cancer. In partnership with leading academic medical centers – Memorial Sloan Kettering Cancer Center, Montefiore Health System, Mount Sinai Health System – and ProHEALTH as manager, the New York Proton Center brings together expert oncologists, clinical care teams, and researchers to improve cancer care and advance the clinical evidence for proton therapy.
